Orthopedic surgery

Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia

Retrieved on: 
Monday, April 8, 2024

Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty

Key Points: 
  • Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty
    Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announced an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT™ in Australia during the recent Australian Orthopedics Association COE Meeting in Sydney.
  • This exclusive distribution builds upon the agreement Smith+Nephew announced for Japan in April 2023.
  • Lynette Walter, NAVBIT’s CEO said, “We are absolutely delighted to expand our partnership with Smith+Nephew into the Australian market.
  • Today we have higher expectations around the accuracy and precision of our surgery,” said Professor Bill Walter, Orthopaedic Surgeon and Founder of NAVBIT.

Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer

Retrieved on: 
Friday, April 5, 2024

Zach Fleming, Sanara's Chief Executive Officer, stated, “Jake and Tyler are seasoned executives with a wealth of experience in the medical device and wound care industries.

Key Points: 
  • Zach Fleming, Sanara's Chief Executive Officer, stated, “Jake and Tyler are seasoned executives with a wealth of experience in the medical device and wound care industries.
  • Mr. Palmer brings extensive expertise in the healthcare sector, particularly in leading strategic growth and corporate development initiatives aimed at enhancing financial and clinical outcomes for providers, while maximizing shareholder returns.
  • In his most recent role, Mr. Palmer served as the Senior Vice President of Corporate Development, Strategy, and Product at AQuity Solutions, a leading provider of outsourced revenue cycle and clinical documentation solutions.
  • Under his leadership, he crafted and executed a strategic vision that included multiple successful acquisitions and technology investments.

Penn Highlands Healthcare Doctors Beyond the Borders

Retrieved on: 
Wednesday, March 20, 2024

Penn Highlands Healthcare offers 849 physicians who provide a wide range of care and treatments at locations throughout 26 counties in Pennsylvania.

Key Points: 
  • Penn Highlands Healthcare offers 849 physicians who provide a wide range of care and treatments at locations throughout 26 counties in Pennsylvania.
  • Penn Highlands Healthcare physicians can be found in the health system’s eight hospitals as well as many community medical buildings, outpatient facilities, surgery centers and physician practices.
  • Some Penn Highlands Healthcare physicians do not allow county, state or continental borders to keep them from providing care where it is needed.
  • Dr. Sergent, who is an emergency medicine physician and the Central Region Medical Director of Emergency Medicine at Penn Highlands Healthcare, shares his skills and expertise beyond the U.S. borders in Central and South America.

Summit Health Names Timothy Reish, M.D., Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry

Retrieved on: 
Tuesday, April 2, 2024

Timothy Reish, M.D., has been named Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry of Summit Health’s NY South region.

Key Points: 
  • Timothy Reish, M.D., has been named Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry of Summit Health’s NY South region.
  • He has been a practicing Orthopedic Surgeon in New York City for more than 20 years.
  • “We are thrilled that Dr. Reish will be leading three of our key departments that are essential to the health and well-being of our patients throughout their lifetime,” said Christine Masterson, M.D., executive vice president at Summit Health.
  • “I look forward to helping our Orthopedics, and Sports Medicine, Pain Management and Podiatry departments stay at the forefront of healthcare by offering the latest advancements and cutting-edge techniques in the fields of Orthopedics and Sports Medicine, Pain Management and Podiatry,” said Dr. Reish.

Miach Orthopaedics Raises $20 Million in Series B Extension

Retrieved on: 
Tuesday, April 2, 2024

Miach Orthopaedics, Inc. , a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced closing of a $20 million Series B extension financing round.

Key Points: 
  • Miach Orthopaedics, Inc. , a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced closing of a $20 million Series B extension financing round.
  • The BEAR Implant is the first disruptive technology in ACL tear treatment in more than 30 years.
  • It is a paradigm shift from the current standard of care – reconstruction that replaces the ACL with a graft.
  • “This Series B extension diversifies Miach’s investor group and provides additional resources to further market growth in the U.S. toward the goal of establishing the BEAR Implant as a new standard of care for ACL tears.”
    For more information about the BEAR Implant, visit miachortho.com .

Adtalem Achieves 97% First-Time Residency Attainment Rate and Growing1

Retrieved on: 
Monday, March 25, 2024

These students and graduates will aid in combating the physician shortage that could exceed 120,000 by 2034.

Key Points: 
  • These students and graduates will aid in combating the physician shortage that could exceed 120,000 by 2034.
  • The success of this year's match reflects the quality of Adtalem's programs and the strong demand for its medical school graduates.
  • For comprehensive lists of residency placements, please visit the AUC and RUSM websites.
  • To learn more about Adtalem’s Match Day 2024, visit the Adtalem Newsroom .

Six-year Children’s Hospital Los Angeles Study Shows That Burnout Is Causing Children to Leave Organized Sports

Retrieved on: 
Wednesday, March 13, 2024

And, according to Bianca Edison, MD, MS , it can have lasting impacts on lifelong health.

Key Points: 
  • And, according to Bianca Edison, MD, MS , it can have lasting impacts on lifelong health.
  • Kids have more and different opportunities to play organized sports than their parents ever had.
  • Participating in these activities is a critical stepping stone in development, according to Dr. Edison, Attending Physician in the Jackie and Gene Autry Orthopedic Center at Children’s Hospital Los Angeles.
  • In addition to the added pressures of high school, burnout can cause children to quit sports.

ENSEMBLE ORTHOPEDICS ANNOUNCES 700TH IMPLANTATION OF ITS MINIMALLY-INVASIVE PYROCARBON INTERPOSITIONAL CMC

Retrieved on: 
Thursday, April 4, 2024

AUSTIN, Texas, April 4, 2024 /PRNewswire/ -- Ensemble Orthopedics Inc, today announced the 700th implantation of the FDA-cleared Ensemble CMC™.

Key Points: 
  • AUSTIN, Texas, April 4, 2024 /PRNewswire/ -- Ensemble Orthopedics Inc, today announced the 700th implantation of the FDA-cleared Ensemble CMC™.
  • "Osteoarthritis of the hand is a debilitating disease that affects 40% of U.S. adults by age 85," said William Ogilvie, President and CEO of Ensemble Orthopedics.
  • Since the launch of the device, Ensemble Orthopedics has enjoyed a doubling of company sales year-over-year for the last three years.
  • Beyond the CMC, Ensemble is dedicated to bringing this stemless, interpositional philosophy to other joints of the hand and wrist.

REGENATIVE LABS' LATEST PUBLISHED STUDY DEMONSTRATES THE SAFETY AND EFFICACY OF WHARTON'S JELLY CONNECTIVE TISSUE ALLOGRAFT FOR ROTATOR CUFF TEARS

Retrieved on: 
Thursday, April 4, 2024

PENSACOLA, Fla., April 4, 2024 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.

Key Points: 
  • PENSACOLA, Fla., April 4, 2024 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.
  • Patients in need of rotator cuff repairs often seek minimally invasive options, making Wharton's Jelly a promising alternative for musculoskeletal defects.
  • Utilizing the structural connective tissue allografts has allowed many patients to avoid surgery altogether and significantly improve their quality of life."
  • The study titled "Safety and Efficacy of Wharton's Jelly Connective Tissue Allograft for Rotator Cuff Tears," was published by MDPI and can be accessed in its entirety here.

OFFICIAL LAUNCH OF THE NATIONAL UNIVERSITY SPINE INSTITUTE (NUSI): LEADING SPINE CARE INTO THE FUTURE

Retrieved on: 
Saturday, March 30, 2024

SINGAPORE, March 30, 2024 /PRNewswire/ -- The National University Spine Institute (NUSI) is a new dedicated specialist spine institute under the National University Health System (NUHS) that provides multidisciplinary care for patients with spinal diseases and deformities.

Key Points: 
  • SINGAPORE, March 30, 2024 /PRNewswire/ -- The National University Spine Institute (NUSI) is a new dedicated specialist spine institute under the National University Health System (NUHS) that provides multidisciplinary care for patients with spinal diseases and deformities.
  • Under the leadership of Associate Professor Gabriel Liu, NUSI aims to set new standards in spine care through a patient-centric approach.
  • A/Prof Liu said: "NUSI differentiates itself by providing dedicated sub-specialties within the spine practice, standardising work processes and providing value-driven patient care across the cluster to address spinal problems.
  • NUSI is dedicated to developing community care programmes for patients, with cases expected to rise in the coming years partly due to an ageing population."